U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Naltrexone Hydrochloride Tablet
Status: Currently in Shortage
»Date first posted: 02/29/2024
»Therapeutic Categories: Analgesia/Addiction

Expand all

Accord Healthcare Inc. (Reverified 03/05/2024)

Company Contact Information:
866-941-7875, option 2

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Tablet, 50 mg (NDC 16729-081-01) Unavailable Shortage of an active ingredient
Tablet, 50 mg (NDC 16729-081-10) Available

Elite Laboratories, Inc. (Reverified 04/15/2024)

Company Contact Information:
800-397-9228

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Tablet, 50 mg (NDC 51224-206-50) Available Marketed by Tagi Pharma
Tablet, 50 mg (NDC 51224-206-30) Available Marketed by Tagi Pharma
Tablet, 50 mg (NDC 68094-909-50) Available Marketed by Precision Dose
Tablet, 50 mg (NDC 68094-909-30) Available Marketed by Precision Dose

SpecGx LLC (Reverified 03/20/2024)

Company Contact Information:
800-325-8888

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Tablet, 50 mg (NDC 0406-1170-01) Limited Availability Long term allocations to primary customers with intermittent backorder expected. Demand increase for the drug
Tablet, 50 mg (NDC 0406-1170-03) Limited Availability Long term allocations to primary customers with intermittent backorder expected. Demand increase for the drug

Sun Pharmaceutical Industries, Inc. (Revised 03/15/2024)

Company Contact Information:
800-818-4555

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Tablet, 50 mg (NDC 47335-326-88) Limited Availability Expected to release in March 2024 Shortage of an active ingredient
Tablet, 50 mg (NDC 47335-326-83) Limited Availability Expected to release in March 2024 Shortage of an active ingredient
Tablet, 50 mg (NDC 47335-326-08) Unavailable Shortage of an active ingredient
Tablet, 50 mg (NDC 47335-326-18) Unavailable Shortage of an active ingredient
Back to Top